Inari Medical (NARI)
(Delayed Data from NSDQ)
$41.82 USD
-0.99 (-2.31%)
Updated May 8, 2024 04:00 PM ET
After-Market: $41.80 -0.02 (-0.05%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth F Momentum F VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
NARI 41.82 -0.99(-2.31%)
Will NARI be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for NARI based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for NARI
Inari Medical (NARI) Q1 Earnings Miss Estimates, OpEx Rises
Inari Medical, Inc. (NARI) Reports Q1 Loss, Tops Revenue Estimates
NARI: What are Zacks experts saying now?
Zacks Private Portfolio Services
What's in Store for These 5 Medical Device Stocks in Q1 Earnings?
Why You Should Retain Inari Medical (NARI) Stock for Now
Inari Medical (NARI) Up 4% Since Last Earnings Report: Can It Continue?
Other News for NARI
Inari Medical management to meet with BTIG
Inari Medical to Participate in the 2024 Bank of America Securities Healthcare Conference
Inari Medical management to meet with BTIG
Director William Hoffman Sells Shares of Inari Medical Inc (NARI)
Baron Discovery Fund Q1 2024 Shareholder Letter